Completed NA INTERVENTIONAL 2-arm NCT02353312

Rhode Island Diastolic Dysfunction - Heart Failure (RIDD-HF)

Sponsor: BioMarin Pharmaceutical

Conditions Cardiovascular Disease Heart Failure

Interventions Kuvan

Updated 7 times since 2017 Last updated: Jul 1, 2025 Started: Mar 31, 2015 Primary completion: Dec 31, 2018 Completion: Dec 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Cardiovascular Disease and Heart Failure, this trial is completed. The trial is conducted by BioMarin Pharmaceutical and has accumulated 7 data snapshots since 2015. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

7 versions recorded

Aug 2025 — Present [monthly]

Completed NA
Sep 2024 — Aug 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Feb 2019 — Jan 2021 [monthly]

Completed NA

Status: Recruiting → Completed

▶ Show 2 earlier versions

Jun 2018 — Feb 2019 [monthly]

Recruiting NA
Jan 2017 — Jun 2018 [monthly]

Recruiting NA

First recorded

Mar 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

BioMarin Pharmaceutical
Lifespan
Providence VA Medical Center

Data source: Providence VA Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Providence, United States